CSat Investment Advisory’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $942K | Buy |
3,369
+166
| +5% | +$46.4K | 0.79% | 38 |
|
|
2020
Q4 | $784K | Sell |
3,203
-288
| -8% | -$70.5K | 0.73% | 52 |
|
|
2020
Q3 | $991K | Buy |
3,491
+929
| +36% | +$264K | 0.09% | 102 |
|
|
2020
Q2 | $686K | Buy |
2,562
+231
| +10% | +$61.9K | 0.08% | 132 |
|
|
2020
Q1 | $738K | Sell |
2,331
-114
| -5% | -$36.1K | 0.16% | 89 |
|
|
2019
Q4 | $726K | Sell |
2,445
-114
| -4% | -$33.9K | 0.19% | 96 |
|
|
2019
Q3 | $595K | Buy |
2,559
+2,203
| +619% | +$512K | 0.19% | 91 |
|
|
2019
Q2 | $83K | Buy |
356
+340
| +2,125% | +$79.3K | 0.03% | 329 |
|
|
2019
Q1 | $4K | Buy |
16
+2
| +14% | +$500 | ﹤0.01% | 509 |
|
|
2018
Q4 | $4K | Buy |
14
+5
| +56% | +$1.43K | ﹤0.01% | 495 |
|
|
2018
Q3 | $3K | Sell |
9
-1
| -10% | -$333 | ﹤0.01% | 501 |
|
|
2018
Q2 | $3K | Buy |
+10
| New | +$3K | ﹤0.01% | 499 |
|